Bayer Aktiengesellschaft (BAYRY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
15.72-1.07 (-6.37%)
At close: 3:59PM EST
| Previous close | 16.79 |
| Open | 16.09 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 15.35 - 16.14 |
| 52-week range | 11.65 - 21.05 |
| Volume | 715,577 |
| Avg. volume | 538,723 |
| Market cap | 61.601B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 8.52 |
| EPS (TTM) | 1.84 |
| Earnings date | N/A |
| Forward dividend & yield | 0.76 (4.54%) |
| Ex-dividend date | 29 Apr 2020 |
| 1y target est | 18.40 |
- Zacks
Regeneron (REGN) Q4 Earnings, Sales Beat on Solid Dupixent Show
Regeneron (REGN) beats on Q4 earnings and sales on solid performance of Dupixent, Eylea and incremental contribution from oncology drug, Libtayo.
- Zacks
Bayer (BAYRY) Gets a Boost With Product Approvals and Deals
Bayer (BAYRY) gets a boost as it wins approvals for a few candidates and enters into collaboration agreements.
- Zacks
Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal
Merck (MRK), Glaxo (GSK), AstraZeneca (AZN) and J&J (JNJ) announce FDA approvals.
© 2021 Verizon Media. All rights reserved.
